Atai Beckley Inc. ( ATAI) - Key Metrics
Stock symbol ATAI is outdated, potentially delisted? Maybe it is available on other exchange?
ATAI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.09 | -$0.10 | -$0.10 |
| 2026Q1 | $0 | -$0.08 | -$0.06 | -$0.06 |
| 2025Q4 | $0 | -$2.45 | -$0.22 | -$0.22 |
| 2025Q3 | $0 | -$0.28 | -$0.11 | -$0.13 |
| 2025Q2 | $0 | -$0.14 | -$0.07 | -$0.10 |
ATAI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -14.61 |
| 2026Q1 | 0% | -11.06 |
| 2025Q4 | 0% | -0.42 |
| 2025Q3 | 0% | -4.72 |
| 2025Q2 | 0% | -3.91 |
ATAI
Price: $7.35
52 week price:
Earnings Per Share: -2.79 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 1.5 million
Ebitda: 9.8 millionMarket Capitalization: 2.7 billion